CERT Investors Have Opportunity to Join Certara, Inc. Fraud Investigation with the Schall Law Firm

LOS ANGELES, June 8, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Certara, Inc. ("Certara" or "the Company") (NASDAQ: CERT) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

PRNewsWire • 15 hours ago

Certara Outlines AI Push, Cost Cuts and New Growth Engines at Jefferies Conference

Certara NASDAQ: CERT executives outlined the company's strategic realignment, artificial intelligence initiatives and cost priorities during a discussion at Jefferies' 2026 Global Healthcare Conference, with newly appointed Chief Executive Officer Jon Resnick saying the company is focused on creating clearer growth engines and improving execution.

MarketBeat • Jun 7, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT

NEW YORK, June 4, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Certara, Inc. ("Certara" or the "Company") (NASDAQ: CERT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

PRNewsWire • Jun 4, 2026

Certara, Inc. (CERT) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Certara, Inc. (CERT) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Seeking Alpha • Jun 3, 2026

Cerrado Gold Inc. (CERT:CA) Q1 2026 Earnings Call Transcript

Cerrado Gold Inc. (CERT:CA) Q1 2026 Earnings Call Transcript

Seeking Alpha • May 29, 2026

CERT SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

NEW YORK, May 22, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Certara, Inc. (“Certara” or the “Company”) (NASDAQ:CERT) investors concerning the Company's and/or members of its senior management's possible violation of the federal securities laws or other unlawful business practices.

GlobeNewsWire • May 22, 2026

Certara, Inc. (CERT) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

Certara, Inc. (CERT) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

Seeking Alpha • May 19, 2026

Certara to Participate in Upcoming Investor Conferences

RADNOR, Pa., May 18, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences:

GlobeNewsWire • May 18, 2026

CERTARA INVESTOR ALERT: Bragar Eagel & Squire, P.C. is Investigating Certara, Inc. on Behalf of Certara Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In Certara (CERT) To Contact Him Directly To Discuss Their Options

GlobeNewsWire • May 15, 2026

CERTARA, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against Certara, Inc. (“Certara” or the “Company”) (NASDAQ:CERT). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On May 11, 2026, Certara reported its first quarter 2026 financial results. Certara disclosed that service.

Business Wire • May 13, 2026